News

DOC fellowship recipient Elise Sylvander develops safety system for CAR T-cells

DOC fellowship recipient Elise Sylvander develops safety system for CAR T-cells (Vienna, 24.5.2022) Congratulations to Elise Sylvander on receiving a DOC fellowship of the Austrian Academy of Sciences. The aim of her fellowship is to (further) develop a molecular on-switch allowing to activate therapeutic CAR T-cells, once they have been administered to the patient. “CAR

DOC fellowship recipient Elise Sylvander develops safety system for CAR T-cells Read More »

Austrian Academy of Sciences appoints Kaan Boztug as corresponding member

Austrian Academy of Sciences appoints Kaan Boztug as corresponding member (Vienna, 13.5.2022) Congratulations to St. Anna CCRI’s scientific director Kaan Boztug, who has been elected a corresponding member of the Austrian Academy of Sciences. The Austrian Academy of Sciences (OeAW) has elected 45 new members. In this year’s elections, 14 female researchers and 31 male

Austrian Academy of Sciences appoints Kaan Boztug as corresponding member Read More »

Sabine Taschner-Mandl earns FWF-Grant

Sabine Taschner-Mandl earns FWF-Stand-Alone-Grant (Vienna, 10.4.2022) Congratulations to Sabine Taschner-Mandl, PhD, and her team on being awarded a Stand-Alone Grant by the Austrian Science Fund FWF. “We aim at mapping tumor metastases by multi-modal imaging to better understand the heterogeneity of childhood nerve tumors and their microenvironment. Mapping tumor cell dissemination can help to refine

Sabine Taschner-Mandl earns FWF-Grant Read More »

Day of Immunology: The interface of immune disorders & cancer

Day of Immunology: A day, to shed light on the interface of immune disorders & cancer (Vienna, 29.4.2022) On today’s International Day of Immunology, we would like to raise awareness for the important research on congenital immune disorders. They are often associated with an increased susceptibility to the development of cancer and are a special

Day of Immunology: The interface of immune disorders & cancer Read More »

Highlighting the relevance of chromosome 21 for childhood lymphoblastic leukemia

Chromosome 21 is the most affected chromosome in childhood acute lymphoblastic leukemia. Many of its numerical and structural abnormalities define diagnostically and clinically important subgroups. In their recent publication, investigators from St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital and Labdia Labordiagnostik GmbH have now provided a comprehensive overview of all these types

Highlighting the relevance of chromosome 21 for childhood lymphoblastic leukemia Read More »

Top leukemia expert worldwide: Michael Dworzak

Top leukemia expert worldwide: Michael Dworzak awarded by independent ranking platform Developing new diagnostic methods for early detection and effective therapy of children and adolescents with leukemia – Univ.-Doz. Dr. Michael Dworzak’s research pursues goals that are vital for pediatric cancer patients. For his tireless efforts, he has now been honored by the international evaluation

Top leukemia expert worldwide: Michael Dworzak Read More »

The god of sun at the forefront of immunodeficiency-research

The god of sun at the forefront of immunodeficiency-research Scientists link mutations in the transcription factor Helios to a novel disease characterized by immunodeficiency and immune dysregulation. When scientists at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) identified an immune dysregulation caused by a biallelic germline mutation affecting Helios – a transcription factor

The god of sun at the forefront of immunodeficiency-research Read More »

Alternative method to animal testing for developing therapies

Tackling two tasks at once: Alternative method to animal testing for developing therapies against childhood cancer Congratulations to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) scientists Univ. Prof. Dr. Heinrich Kovar and Dr. Branka Radic-Sarikas for winning a grant from the Austrian Science Fund (FWF) under the program “Alternative methods to animal testing”.

Alternative method to animal testing for developing therapies Read More »

Congrats to Davide Seruggia for receiving the ISTT Young Investigator Award!

ISTT Young Investigator Award 2021! The ISTT (International Society for Transgenic Technologies) Young Investigator Award identifies and recognizes young scientists who advance the science and technologies in the generation and analysis of transgenic animal models for biomedical research and biotechnology applications. Davide Seruggia received the award for his successful complex projects requiring advanced CRISPR technology:

Congrats to Davide Seruggia for receiving the ISTT Young Investigator Award! Read More »